Author | Kathryn Wheeler, PharmD, BCPS


Barhemsys (Amisulpride) for Postoperative Nausea and Vomiting

June 22, 2020

On February 27, 2020, the FDA approved an intravenous solution of amisulpride (Barhemsys; Acacia Pharma) to treat and prevent postoperative nausea and vomiting.

Lumateprone Tosylate Approved for Schizophrenia

April 09, 2020

The FDA has approved lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) for treatment of schizophrenia in adults.

Ubrogepant: A Novel Drug Mechanism for Migraine Treatment

March 17, 2020

On December 23, 2019, the FDA approved ubrogepant for the acute treatment of migraine with and without aura in adult patients.

New Drug Review: Zulresso (Brexanolone)

June 24, 2019

The first drug approved to specifically treat post-partum depression.